Three-year outcomes with left ventricular assist devices in country with restricted heart transplantation
نویسندگان
چکیده
منابع مشابه
Three-year outcomes with left ventricular assist devices in country with restricted heart transplantation
Background/Introduction As a consequence of limited donor availability, there has been a growing interest for alternative strategies, such as left ventricular assist devices (LVAD) as either a bridge to transplantation (BTT) or as destination therapy (DT) for the treatment of the advanced heart failure. The heart transplant program in Kazakhstan is in a nascent stage and therefore patients that...
متن کاملInitial 3‐year outcomes with left ventricular assist devices in a country with a nascent heart transplantation program
AIMS The need for the left ventricular assist devices (LVAD) in patients with end-stage heart failure is well established, but prior to 2011, this was not available to patients in Kazakhstan. We describe the development of the sole LVAD programme in the context of a nascent heart transplantation programme and clinical outcomes for the first three years. METHODS AND RESULTS From November 2011 ...
متن کاملFour-year outcomes with third-generation centrifugal left ventricular assist devices in an era of restricted transplantation
OBJECTIVES Third-generation ventricular assist devices (VADs) are associated with improved outcomes, though in recent clinical trials bridge-to-transplant (BTT) rates are ∼30% at 6 months, so that transplantation can be used as a 'bail out' for serious complications. In the UK, there was a significant reduction in heart transplantation rates over the last decade, so that transplantation from VA...
متن کاملEffects of left ventricular assist devices on outcomes in patients undergoing heart transplantation.
BACKGROUND Left ventricular assist devices (LVADs) are increasingly being used to "bridge" patients to heart transplantation. METHODS Data from 40 consecutive status 1 heart transplantation patients treated with intravenous inotrope therapy (n = 20) or the HeartMate LVAD (n = 20) were retrospectively analyzed. RESULTS Baseline clinical characteristics were similar in the two groups. At the ...
متن کاملOutcomes in advanced heart failure patients with left ventricular assist devices for destination therapy.
BACKGROUND The HeartMate II (HMII) destination therapy (DT) trial demonstrated significant improvements in outcomes in continuous-flow left ventricular assist devices compared with patients implanted with the pulsatile-flow HeartMate XVE. The primary hypothesis of the current study is that trial patients enrolled after the initial data cohort would have better clinical outcomes. METHODS AND R...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Cardiothoracic Surgery
سال: 2015
ISSN: 1749-8090
DOI: 10.1186/1749-8090-10-s1-a32